NOV vs INVX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

NOV

46.0
AI Score
VS
NOV Wins

INVX

39.8
AI Score

Investment Advisor Scores

NOV

46score
Recommendation
HOLD

INVX

40score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric NOV INVX Winner
Forward P/E 22.0751 0 Tie
PEG Ratio 1.1592 0 Tie
Revenue Growth -2.5% 9.2% INVX
Earnings Growth 7.6% 63.6% INVX
Tradestie Score 46.0/100 39.8/100 NOV
Profit Margin 1.1% 6.2% INVX
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL NOV

Relative Price Performance (Last 90 Days)

NOV 1M: +1.4% · 3M: -2.1% INVX 1M: +9.9% · 3M: -4.9%

Current Technical Phase

NOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.0 · Price: $20.42

INVX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 53

RSI (14): 53.4 · Price: $29.32

Fundamentals Snapshot

Metric NOV INVX
Market Cap
Forward P/E 16.2 14.9
Trailing P/E 78.0 33.1
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.1%
EPS 0.26 0.88
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, NOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.